- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Small Cap High Growth Stocks
U.S. Pharmaceuticals & Biotech Small Cap High Growth Stocks
UPDATED Apr 11, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
51 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
OTLK | US$9.04 | -5.0% | -57.8% | US$194.0m | US$39.86 | PE-3.8x | E61.3% | n/a | ||
ZYNE | US$1.30 | 4.0% | 96.1% | US$65.6m | US$1.26 | PB2.3x | E67.2% | n/a | ||
FRLN | US$6.48 | -0.2% | -21.7% | US$28.3m | US$8.25 | PS45.4x | E60.7% | n/a | ||
OPNT | US$20.65 | -1.3% | -22.3% | US$108.8m | US$21.50 | PS4.9x | E62.6% | n/a | ||
ESPR | US$2.31 | -25.7% | 71.1% | US$466.3m | US$7.41 | PS3.7x | E59.2% | n/a | ||
EVAX | US$3.89 | 6.6% | -67.9% | US$20.8m | US$11.75 | PS277.9x | E64.7% | n/a | ||
FENC | US$10.83 | -0.7% | 26.4% | US$289.2m | US$18.33 | PS13.8x | E50.8% | n/a | ||
PLX | US$1.22 | 0.8% | -51.0% | US$92.0m | US$13.00 | PE10.7x | E96.5% | n/a | ||
SCPH | US$5.10 | -0.8% | -55.6% | US$172.3m | US$19.50 | PS13.5x | E59.8% | n/a | ||
DARE | US$0.48 | -5.3% | -52.3% | US$48.1m | US$4.00 | PS17.3x | E71.8% | n/a | ||
HROW | US$13.19 | 0.3% | -40.4% | US$457.2m | US$27.53 | PS3.6x | E69.3% | n/a | ||
YS | US$0.86 | -3.7% | -39.9% | US$169.5m | US$4.29 | PS2.1x | E56.6% | n/a | ||
CDXC | US$4.09 | -5.3% | 178.2% | US$295.9m | US$6.08 | PS3.7x | E93.2% | n/a | ||
IPA | US$1.37 | -5.5% | -51.4% | US$36.6m | US$7.00 | PS2.1x | E61.2% | n/a | ||
CDMO | US$6.90 | 8.8% | -67.0% | US$436.4m | US$12.25 | PS3.1x | E86.4% | n/a | ||
HRTX | US$2.94 | 14.4% | 2.1% | US$410.4m | US$7.00 | PS3.5x | E68.5% | n/a | ||
LJPC | US$6.22 | 0.5% | 59.1% | US$155.1m | US$6.23 | PE39.1x | E59.0% | n/a | ||
CHRS | US$2.41 | 3.4% | -70.4% | US$276.2m | US$7.80 | PS1.1x | E79.7% | n/a | ||
EBS | US$2.19 | -3.5% | -82.6% | US$116.4m | US$5.00 | PB0.2x | E148.6% | n/a | ||
XERS | US$2.03 | -1.0% | -6.9% | US$278.1m | US$4.75 | PS1.7x | E62.1% | n/a | ||
NBY | US$0.09 | -14.3% | -94.3% | US$2.8m | US$3.35 | PB2x | E130.1% | n/a | ||
AMRN | US$1.02 | -3.8% | -27.7% | US$427.1m | US$1.08 | PS1.4x | E51.2% | n/a | ||
BTMD | US$5.99 | 4.2% | -0.5% | US$374.5m | US$8.65 | PE61.6x | E49.4% | n/a | ||
LFCR | US$6.17 | 0.8% | 55.0% | US$178.7m | US$6.00 | PS1.8x | E138.1% | n/a |